The question of what causes complex neurological diseases such as Alzheimer’s or multiple sclerosis continues to confound scientists and doctors, with the unknowns standing in the way of early diagnoses and effective treatments.
Innovative malaria prodrug targets liver, enhances efficacy while reducing toxicity, preclinical studies show
Tafenoquine, a prodrug that could fulfill the criteria for a mass eradication campaign.
April 23, 2024